期刊
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
卷 162, 期 1, 页码 27-29出版社
SPRINGER
DOI: 10.1007/s10517-016-3536-6
关键词
heart; ischemia; reperfusion; postconditioning
资金
- Russian Science Foundation [14-15-00008]
- Russian Science Foundation [14-15-00008] Funding Source: Russian Science Foundation
- British Heart Foundation [PG/15/66/31710] Funding Source: researchfish
CB receptor agonist HU-210 exhibits an infarction-limiting effect during in vitro reperfusion of the heart after focal ischemia. This effect is paralleled by a decrease in left-ventricular developed pressure and double product. In addition, HU-210 reduces end-diastolic pressure during the reperfusion period, which indirectly attests to reduced Ca2+ overload of cardiomyocytes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
